ClinicalTrials.Veeva

Menu

Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry

Cedars-Sinai Medical Center logo

Cedars-Sinai Medical Center

Status

Enrolling

Conditions

Bicuspid Aortic Valve

Treatments

Device: Transcatheter aortic valve replacement

Study type

Observational

Funder types

Other

Identifiers

NCT03836521
Pro00047203

Details and patient eligibility

About

The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.

Enrollment

2,000 estimated patients

Sex

All

Ages

19 to 129 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age≥18 years.
  2. Severe aortic stenosis with bicuspid anatomy.
  3. NYHA≥2 and/or syncope and/or angina.
  4. Patient judged by the Heart Team as indicated for TAVR.

Exclusion criteria

  1. Age <18 years
  2. Asymptomatic patients
  3. Pure aortic regurgitation.

Trial contacts and locations

1

Loading...

Central trial contact

Sung-Han Yoon, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems